Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Erythematosus, Systemic | 11 | 2022 | 2099 | 1.550 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 8 | 2023 | 546 | 1.520 |
Why?
|
Macrophage Activation Syndrome | 5 | 2023 | 111 | 0.770 |
Why?
|
Rheumatology | 5 | 2023 | 576 | 0.640 |
Why?
|
Thyroglobulin | 1 | 2017 | 114 | 0.600 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2020 | 657 | 0.580 |
Why?
|
Milk Proteins | 1 | 2017 | 169 | 0.580 |
Why?
|
Antirheumatic Agents | 6 | 2023 | 1335 | 0.570 |
Why?
|
Hashimoto Disease | 1 | 2017 | 93 | 0.570 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2023 | 609 | 0.560 |
Why?
|
Rheumatic Diseases | 4 | 2023 | 590 | 0.510 |
Why?
|
Coronary Aneurysm | 3 | 2023 | 237 | 0.460 |
Why?
|
Uveitis | 3 | 2022 | 375 | 0.420 |
Why?
|
Immunosuppressive Agents | 3 | 2017 | 4147 | 0.350 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1780 | 0.340 |
Why?
|
T-Lymphocytes | 5 | 2021 | 10163 | 0.320 |
Why?
|
Immunologic Factors | 1 | 2017 | 1575 | 0.320 |
Why?
|
Immunocompromised Host | 1 | 2012 | 847 | 0.300 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2022 | 256 | 0.300 |
Why?
|
Musculoskeletal Diseases | 2 | 2023 | 581 | 0.290 |
Why?
|
Interferon-beta | 2 | 2005 | 323 | 0.290 |
Why?
|
Interferon-alpha | 2 | 2012 | 895 | 0.270 |
Why?
|
Respiratory Tract Infections | 2 | 2012 | 959 | 0.270 |
Why?
|
Viral Nonstructural Proteins | 1 | 2005 | 241 | 0.230 |
Why?
|
Child | 26 | 2023 | 77478 | 0.220 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2005 | 137 | 0.220 |
Why?
|
Organ Transplantation | 1 | 2012 | 1135 | 0.210 |
Why?
|
Synovial Fluid | 2 | 2021 | 394 | 0.200 |
Why?
|
Parotitis | 1 | 2021 | 29 | 0.200 |
Why?
|
Autoantibodies | 3 | 2023 | 2036 | 0.190 |
Why?
|
Agammaglobulinemia | 1 | 2022 | 167 | 0.190 |
Why?
|
Interferon Type I | 1 | 2023 | 542 | 0.180 |
Why?
|
Sjogren's Syndrome | 1 | 2021 | 229 | 0.170 |
Why?
|
Child, Preschool | 13 | 2023 | 40955 | 0.170 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 297 | 0.170 |
Why?
|
Eosinophilia | 1 | 2023 | 531 | 0.160 |
Why?
|
Uveitis, Anterior | 1 | 2019 | 101 | 0.160 |
Why?
|
Interleukin-2 | 2 | 2018 | 1887 | 0.160 |
Why?
|
Methotrexate | 3 | 2021 | 1720 | 0.160 |
Why?
|
Cell Polarity | 1 | 2021 | 644 | 0.160 |
Why?
|
Receptors, Interleukin-2 | 1 | 1999 | 573 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2019 | 241 | 0.150 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 391 | 0.150 |
Why?
|
Severe Combined Immunodeficiency | 1 | 1999 | 221 | 0.150 |
Why?
|
Interferons | 2 | 2018 | 704 | 0.150 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 438 | 0.150 |
Why?
|
Coronary Vessels | 2 | 2020 | 3099 | 0.150 |
Why?
|
Arthralgia | 1 | 2021 | 456 | 0.150 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2021 | 2986 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 540 | 0.140 |
Why?
|
Humans | 48 | 2023 | 742088 | 0.140 |
Why?
|
Pediatrics | 2 | 2022 | 3462 | 0.140 |
Why?
|
rho-Associated Kinases | 1 | 2018 | 279 | 0.140 |
Why?
|
Protein Kinase C-delta | 1 | 2016 | 123 | 0.140 |
Why?
|
Immunoglobulin A | 1 | 2020 | 992 | 0.140 |
Why?
|
Fas Ligand Protein | 1 | 2016 | 217 | 0.140 |
Why?
|
Protease Inhibitors | 1 | 2020 | 790 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17400 | 0.130 |
Why?
|
Endodeoxyribonucleases | 1 | 2016 | 162 | 0.130 |
Why?
|
Exodeoxyribonucleases | 1 | 2016 | 176 | 0.130 |
Why?
|
Trans-Activators | 1 | 2005 | 2924 | 0.130 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2012 | 324 | 0.130 |
Why?
|
Complement System Proteins | 1 | 2018 | 795 | 0.130 |
Why?
|
Adaptive Immunity | 1 | 2020 | 712 | 0.130 |
Why?
|
Antigen-Antibody Complex | 1 | 2016 | 517 | 0.130 |
Why?
|
Cytokines | 4 | 2023 | 7317 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5425 | 0.120 |
Why?
|
Chromosome Disorders | 1 | 2017 | 515 | 0.120 |
Why?
|
Infant | 8 | 2021 | 35070 | 0.120 |
Why?
|
Gene Transfer Techniques | 1 | 1999 | 1224 | 0.120 |
Why?
|
Biological Products | 1 | 2023 | 856 | 0.120 |
Why?
|
Adolescent | 15 | 2022 | 85649 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 807 | 0.120 |
Why?
|
Virus Diseases | 3 | 2005 | 710 | 0.110 |
Why?
|
Biomedical Research | 2 | 2022 | 3306 | 0.110 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 628 | 0.110 |
Why?
|
Th17 Cells | 1 | 2020 | 765 | 0.110 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9639 | 0.110 |
Why?
|
Paramyxoviridae Infections | 1 | 2012 | 55 | 0.110 |
Why?
|
Mutation | 1 | 2017 | 29717 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2018 | 1284 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2020 | 2713 | 0.110 |
Why?
|
Lung Diseases | 1 | 2023 | 1884 | 0.110 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 2271 | 0.110 |
Why?
|
Interleukin-17 | 2 | 2023 | 900 | 0.110 |
Why?
|
Adenovirus Infections, Human | 1 | 2012 | 71 | 0.110 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2012 | 87 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2019 | 1675 | 0.100 |
Why?
|
Phenotype | 2 | 2022 | 16331 | 0.100 |
Why?
|
Drug Resistance | 1 | 2017 | 1608 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1847 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13655 | 0.100 |
Why?
|
Autoimmunity | 1 | 2018 | 1348 | 0.090 |
Why?
|
Hematopoiesis | 1 | 1999 | 2066 | 0.090 |
Why?
|
Pedigree | 1 | 2017 | 4646 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4929 | 0.090 |
Why?
|
Immunity, Innate | 2 | 2020 | 2956 | 0.080 |
Why?
|
Arthritis | 1 | 2014 | 658 | 0.080 |
Why?
|
Adolescent Behavior | 1 | 2017 | 1150 | 0.080 |
Why?
|
Cholesterol | 1 | 2018 | 2895 | 0.080 |
Why?
|
Lymphocytes | 1 | 2016 | 2614 | 0.080 |
Why?
|
Echocardiography | 2 | 2019 | 5097 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2017 | 19223 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2699 | 0.080 |
Why?
|
DNA Damage | 1 | 2018 | 2423 | 0.080 |
Why?
|
Signal Transduction | 6 | 2018 | 23387 | 0.080 |
Why?
|
Molecular Biology | 1 | 2012 | 595 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2016 | 2440 | 0.080 |
Why?
|
B-Lymphocytes | 3 | 2023 | 4664 | 0.080 |
Why?
|
Interleukin-6 | 2 | 2020 | 3199 | 0.070 |
Why?
|
Delphi Technique | 2 | 2021 | 778 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3695 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1952 | 0.070 |
Why?
|
Consensus | 3 | 2021 | 2935 | 0.070 |
Why?
|
Myocardium | 1 | 2020 | 4775 | 0.070 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4328 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7276 | 0.070 |
Why?
|
STAT2 Transcription Factor | 1 | 2005 | 27 | 0.070 |
Why?
|
Animals | 8 | 2020 | 168561 | 0.070 |
Why?
|
Incidence | 2 | 2023 | 20928 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2023 | 77098 | 0.070 |
Why?
|
Environmental Exposure | 1 | 2020 | 4231 | 0.070 |
Why?
|
Logistic Models | 3 | 2021 | 13403 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2021 | 4379 | 0.060 |
Why?
|
Desensitization, Immunologic | 1 | 2010 | 483 | 0.060 |
Why?
|
Female | 17 | 2021 | 379592 | 0.060 |
Why?
|
Respiratory System | 2 | 2005 | 555 | 0.060 |
Why?
|
Male | 15 | 2021 | 349538 | 0.060 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3766 | 0.060 |
Why?
|
STAT1 Transcription Factor | 1 | 2005 | 320 | 0.060 |
Why?
|
Parents | 1 | 2017 | 3387 | 0.060 |
Why?
|
Decision Making | 1 | 2017 | 3869 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18006 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2022 | 62966 | 0.060 |
Why?
|
Interleukin-15 | 1 | 2023 | 184 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9144 | 0.050 |
Why?
|
Young Adult | 4 | 2022 | 56350 | 0.050 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.050 |
Why?
|
Inflammation | 3 | 2020 | 10578 | 0.050 |
Why?
|
Blood-Air Barrier | 1 | 2002 | 25 | 0.050 |
Why?
|
Antiviral Agents | 2 | 2012 | 2978 | 0.050 |
Why?
|
Buprenorphine | 1 | 2010 | 640 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 12946 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2013 | 1794 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 644 | 0.050 |
Why?
|
Hypergammaglobulinemia | 1 | 2021 | 74 | 0.050 |
Why?
|
Influenza, Human | 1 | 2012 | 1472 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7645 | 0.050 |
Why?
|
Drug Hypersensitivity | 1 | 2010 | 883 | 0.050 |
Why?
|
Xerostomia | 1 | 2021 | 95 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12220 | 0.050 |
Why?
|
Rheumatoid Factor | 1 | 2021 | 188 | 0.050 |
Why?
|
MicroRNAs | 1 | 2016 | 3731 | 0.050 |
Why?
|
Vaccination | 2 | 2023 | 3256 | 0.050 |
Why?
|
Registries | 1 | 2016 | 8077 | 0.050 |
Why?
|
Antibodies, Antinuclear | 1 | 2021 | 326 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 132 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2016 | 7873 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5851 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2023 | 1262 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2019 | 231 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4438 | 0.040 |
Why?
|
Mice | 4 | 2020 | 81045 | 0.040 |
Why?
|
Risk Factors | 5 | 2023 | 72145 | 0.040 |
Why?
|
Lymphopenia | 1 | 2021 | 285 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2021 | 317 | 0.040 |
Why?
|
Whole-Body Irradiation | 1 | 1999 | 449 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2019 | 248 | 0.040 |
Why?
|
Time Factors | 2 | 2017 | 40054 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 986 | 0.040 |
Why?
|
Dermatomyositis | 1 | 2019 | 223 | 0.040 |
Why?
|
Boston | 2 | 2021 | 9305 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 773 | 0.040 |
Why?
|
Ferritins | 1 | 2019 | 590 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2005 | 3199 | 0.040 |
Why?
|
Lupus Vasculitis, Central Nervous System | 1 | 2016 | 33 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2021 | 1866 | 0.040 |
Why?
|
Dry Eye Syndromes | 1 | 2021 | 382 | 0.040 |
Why?
|
Th1 Cells | 1 | 2021 | 1056 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 2 | 2016 | 1837 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2002 | 722 | 0.030 |
Why?
|
Fever | 1 | 2023 | 1612 | 0.030 |
Why?
|
Neutropenia | 1 | 2021 | 891 | 0.030 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2016 | 58 | 0.030 |
Why?
|
X Chromosome | 1 | 1999 | 815 | 0.030 |
Why?
|
Immunity | 1 | 2002 | 1011 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2459 | 0.030 |
Why?
|
Cohort Studies | 2 | 2021 | 40450 | 0.030 |
Why?
|
California | 1 | 2019 | 1400 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1200 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3266 | 0.030 |
Why?
|
Adult | 5 | 2022 | 213712 | 0.030 |
Why?
|
Hospitalization | 1 | 2013 | 10232 | 0.030 |
Why?
|
Genetic Linkage | 1 | 1999 | 2422 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2010 | 3667 | 0.030 |
Why?
|
North America | 1 | 2017 | 1249 | 0.030 |
Why?
|
DNA Methylation | 2 | 2021 | 4282 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2011 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1171 | 0.030 |
Why?
|
Lupus Nephritis | 1 | 2016 | 310 | 0.030 |
Why?
|
Toll-Like Receptors | 1 | 2016 | 592 | 0.030 |
Why?
|
Parent-Child Relations | 1 | 2017 | 747 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1459 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2002 | 1093 | 0.030 |
Why?
|
United States | 4 | 2023 | 69693 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4982 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15056 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2016 | 804 | 0.030 |
Why?
|
Age Factors | 2 | 2019 | 18355 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2012 | 742 | 0.020 |
Why?
|
Cell Line | 1 | 2005 | 15994 | 0.020 |
Why?
|
Membrane Microdomains | 1 | 2012 | 202 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2010 | 56 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3618 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15244 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 3038 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1999 | 3420 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9846 | 0.020 |
Why?
|
Asthma | 2 | 2005 | 5955 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29010 | 0.020 |
Why?
|
CpG Islands | 1 | 2012 | 1170 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2016 | 2257 | 0.020 |
Why?
|
Phosphorylation | 2 | 2012 | 8436 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3611 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 23320 | 0.020 |
Why?
|
Cell Separation | 1 | 2012 | 1749 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2012 | 1348 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6483 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2016 | 2723 | 0.020 |
Why?
|
CREB-Binding Protein | 1 | 2005 | 151 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2556 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 24913 | 0.020 |
Why?
|
Aged | 1 | 2017 | 162944 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4751 | 0.020 |
Why?
|
E1A-Associated p300 Protein | 1 | 2005 | 131 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2013 | 1760 | 0.020 |
Why?
|
src Homology Domains | 1 | 2005 | 364 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2699 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14720 | 0.020 |
Why?
|
Quality Improvement | 1 | 2019 | 3738 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21719 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2890 | 0.010 |
Why?
|
Cell Lineage | 1 | 2012 | 2504 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12958 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9826 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3639 | 0.010 |
Why?
|
Middle Aged | 1 | 2017 | 213127 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39004 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4200 | 0.010 |
Why?
|
Retroviridae | 1 | 2005 | 914 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2012 | 2524 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13256 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9941 | 0.010 |
Why?
|
Models, Immunological | 1 | 2005 | 527 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1723 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5975 | 0.010 |
Why?
|
Immunity, Mucosal | 1 | 2005 | 491 | 0.010 |
Why?
|
Immunotherapy | 1 | 2016 | 4414 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19862 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5867 | 0.010 |
Why?
|
Cysteine | 1 | 2005 | 873 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6294 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9715 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9387 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12242 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2013 | 5310 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7770 | 0.010 |
Why?
|
Patient Readmission | 1 | 2013 | 3111 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7790 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7716 | 0.010 |
Why?
|
Calcium | 1 | 2012 | 5753 | 0.010 |
Why?
|
Respiratory Mucosa | 1 | 2002 | 427 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13853 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5892 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15530 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2005 | 2107 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 53187 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12071 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3678 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7289 | 0.010 |
Why?
|
Models, Biological | 1 | 2002 | 9581 | 0.000 |
Why?
|